Additionally, Mirani et al. [46] reported an improvement in the clinical outcome of a small cohort of patients, and the possibility of targeting DPP4 as part of the senescence-associated genes for COVID-19 treatment was discussed by Maremande et al. [47]. Here, DPP4 is linked to COVID-19.